Pear Bankruptcy Filing Highlights Difficult Challenges Facing Digital Therapeutics

 
• By Tim Casey and Reed Miller

Pear Therapeutics filed for Chapter 11 bankruptcy in April and sold its remaining assets in an auction for about $6m. The demise of one the pioneers in the prescription digital therapeutics industry highlights the challenges PDT developers face getting their products reimbursed.

Abstract mash line and point Question mark. Business illustration. Polygonal low poly
• Source: Shutterstock

More from Digital Technologies

More from Medtech Insight